Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis

JAAD International(2021)

Cited 11|Views10
No score
Abstract
Apremilast is a robust antipsoriatic drug for which the drug survival is not strongly influenced by most patient- or disease-related factors except age. Drug survival is significantly shorter in patients younger than 40 years.
More
Translated text
Key words
apremilast,drug survival,psoriasis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined